% | $
Quotes you view appear here for quick access.

SLTM Message Board

  • tripplevy tripplevy Dec 16, 2013 8:44 AM Flag


    December 16, 2013
    New York, New York

    Tripp Levy PLLC, a leading securities and shareholder rights law firm that represents shareholders throughout the nation, announces that it is investigating the acquisition of Solta Medical, Inc. on behalf of its shareholders. Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that it has entered into a definitive agreement under which Valeant will acquire all of the outstanding common stock of Solta Medical, Inc. (SLTM) for $2.92 per share in cash.

    The investigation concerns whether the board of directors of Solta breached their fiduciary duties by not engaging in a full and fair process to insure shareholders received the maximum value for their shares, while not, at the same time, seeking personal benefits for their own self-interests. Indeed, analysts have projected that the true inherent going forward value of Solta is worth at least $4 per share.

    If you are a shareholder of Solta and would like additional information regarding this matter at no cost or expense, please contact us toll free at 1-877-772-3975 or email at contact @ tripplevy

    Tripp Levy PLLC has extensive experience in mergers and takeovers and has assisted in the recovery of hundreds of millions of dollars for shareholders. Attorney advertising. Prior results do not indicate a similar outcome.

    SortNewest  |  Oldest  |  Most Replied Expand all replies